Rice Hall James & Associates LLC Boosts Stake in Ingevity Corporation $NGVT

Rice Hall James & Associates LLC boosted its holdings in Ingevity Corporation (NYSE:NGVT) by 2.3% during the first quarter, Holdings Channel.com reports. The fund owned 345,138 shares of the company’s stock after buying an additional 7,643 shares during the quarter. Ingevity accounts for 1.4% of Rice Hall James & Associates LLC’s investment portfolio, making the stock its 24th largest holding. Rice Hall James & Associates LLC’s holdings in Ingevity were worth $24,584,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in NGVT. Global Retirement Partners LLC bought a new stake in shares of Ingevity during the 4th quarter valued at about $27,000. Meeder Asset Management Inc. bought a new position in shares of Ingevity in the fourth quarter worth approximately $33,000. Geneos Wealth Management Inc. increased its position in shares of Ingevity by 85.8% in the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after purchasing an additional 387 shares during the last quarter. Headlands Technologies LLC bought a new position in shares of Ingevity in the second quarter worth approximately $46,000. Finally, Kestra Advisory Services LLC purchased a new stake in Ingevity in the fourth quarter valued at approximately $47,000. 91.59% of the stock is currently owned by institutional investors.

Insider Transactions at Ingevity

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total value of $33,971.04. Following the completion of the sale, the senior vice president owned 7,202 shares of the company’s stock, valued at $493,264.98. This represents a 6.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.88% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Wall Street Zen upgraded shares of Ingevity from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, July 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a report on Friday, July 17th. Two analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $80.00.

Ingevity Trading Down 0.7%

Shares of NGVT stock opened at $73.28 on Friday. The business has a 50-day moving average price of $71.08 and a two-hundred day moving average price of $70.62. Ingevity Corporation has a 12-month low of $39.74 and a 12-month high of $79.29. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 27.83. The firm has a market cap of $2.55 billion, a P/E ratio of -20.64 and a beta of 1.16.

Ingevity (NYSE:NGVT) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $0.84 by $0.31. The firm had revenue of $258.00 million for the quarter, compared to analyst estimates of $254.73 million. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The company’s revenue was up 4.1% on a year-over-year basis. During the same period in the prior year, the company earned $1.01 EPS. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. Equities analysts anticipate that Ingevity Corporation will post 5.05 EPS for the current fiscal year.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.